Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3
Open accessThe DOI matches its Crossref record; 160 of the 170 references it cites were found in a registry or an index.
Abstract
Vascular endothelial growth factor receptor 3 (VEGFR3) has been known for its involvement in tumor-associated lymphangiogenesis and lymphatic metastasis. The VEGFR3 signaling is stimulated by its main cognate ligand, vascular endothelial growth factor C (VEGF-C), which in turn promotes tumor progression. Activation of VEGF-C/VEGFR3 signaling in lymphatic endothelial cells (LECs) was shown to enhance the proliferation of LECs and the formation of lymphatic vessels, leading to increased lymphatic metastasis of tumor cells. In the past decade, the expression and pathological roles of VEGFR3 in tumor cells have been described. Moreover, the VEGF-C/VEGFR3 axis has been implicated in regulating immune tolerance and suppression. Therefore, the inhibition of the VEGF-C/VEGFR3 axis has emerged as an important therapeutic strategy for the treatment of cancer. In this review, we discuss the current findings related to VEGF-C/VEGFR3 signaling in cancer progression and recent advances in the development of therapeutic drugs targeting VEGF-C/VEGFR3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, no approved therapy for wet AMD targets VEGF-C, a potentially important target and driver of treatment resistance. 21 – 24”
From Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies (2024) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Concentrations of VEGF-A, VEGF-B, and PlGF are elevated in the eyes of individuals with wet AMD compared to healthy controls, 21 , 54 , 55”
From Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies (2024) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In addition, VEGF-C concentrations are reportedly elevated in the eye following treatment with VEGF-A inhibitors, suggesting that VEGF-A suppression induces compensatory upregulation of VEGF-C. 21 , 23 , 24”
From Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies (2024) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060655 · Cited by 4,802
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Sternberg, C. N., Davis, I. D., Mardiak, J., Szczylik, C., Lee, E., Wagstaff, J., Barrios, C. H., Salman, P., Gladkov, O. A., Kavina, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.9764 · Cited by 2,471
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
VEGF-targeted therapy: mechanisms of anti-tumour activity
Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2403 · Cited by 1,673
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,656
Signal transduction by vascular endothelial growth factor receptors
Koch, S., Tugues, S., Li, X., Gualandi, L., & Claesson-Welsh, L. (2011) · Biochemical Journal · doi:10.1042/bj20110301 · Cited by 1,635
Lymphangiogenesis: Molecular Mechanisms and Future Promise
Tammela, T., & Alitalo, K. (2010) · Cell · doi:10.1016/j.cell.2010.01.045 · Cited by 1,441
Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., & Alitalo, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3566 · Cited by 1,423
Karkkainen, M. J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T. V., Jeltsch, M., Jackson, D. G., Talikka, M., Rauvala, H., et al. (2004) · Nature Immunology · doi:10.1038/ni1013 · Cited by 1,421
Kendall, R. L., & Thomas, K. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10705 · Cited by 1,394
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., & Alitalo, K. (1997) · Science · doi:10.1126/science.276.5317.1423 · Cited by 1,283
Achen, M. G., Jeltsch, M., Kukk, E., Mäkinen, T., Vitali, A., Wilks, A. F., Alitalo, K., & Stacker, S. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.548 · Cited by 1,205
Park, J. E., Chen, H. H., Winer, J., Houck, K. A., & Ferrara, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47298-5 · Cited by 1,112
Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) · Nature Medicine · doi:10.1038/nm731 · Cited by 1,068
Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis
Shibuya, M., & Claesson-Welsh, L. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.012 · Cited by 1,062
Functionally specialized junctions between endothelial cells of lymphatic vessels
Baluk, P., Fuxe, J., Hashizume, H., Romano, T., Lashnits, E., Butz, S., Vestweber, D., Corada, M., Molendini, C., Dejana, E., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062596 · Cited by 1,006
Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., & Sato, M. (1990) · PubMed · Cited by 960
Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3
Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M., & Alitalo, K. (1998) · Science · doi:10.1126/science.282.5390.946 · Cited by 874
Makinen, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4762 · Cited by 845
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
Tammela, T., Zarkada, G., Wallgard, E., Murtomäki, A., Suchting, S., Wirzenius, M., Waltari, M., Hellström, M., Schomber, T., Peltonen, R., et al. (2008) · Nature · doi:10.1038/nature07083 · Cited by 813
Lymphangiogenesis and cancer metastasis
Stacker, S. A., Achen, M. G., Jussila, L., Baldwin, M. E., & Alitalo, K. (2002) · Nature Reviews Cancer · doi:10.1038/nrc863 · Cited by 797
Schoppmann, S. F., Birner, P., Stöckl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., & Kerjaschki, D. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64255-1 · Cited by 794
Mäkinen, T., Jussila, L., Veikkola, T., Karpanen, T., Kettunen, M. I., Pulkkanen, K. J., Kauppinen, R., Jackson, D. G., Kubo, H., Nishikawa, S.-I., et al. (2001) · Nature Medicine · doi:10.1038/84651 · Cited by 777
VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
Lohela, M., Bry, M., Tammela, T., & Alitalo, K. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.12.012 · Cited by 738
Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V., & Alitalo, K. (1996) · Development · doi:10.1242/dev.122.12.3829 · Cited by 690
Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema
Karkkainen, M. J., Ferrell, R. E., Lawrence, E. C., Kimak, M. A., Levinson, K. L., McTigue, M. A., Alitalo, K., & Finegold, D. N. (2000) · Nature Genetics · doi:10.1038/75997 · Cited by 650
Identification of a new endothelial cell growth factor receptor tyrosine kinase.
Terman, B. I., Carrion, M. E., Kovacs, E., Rasmussen, B. A., Eddy, R. L., & Shows, T. B. (1991) · Oncogene · Cited by 641
Abnormal lymphatic vessel development in neuropilin 2 mutant mice
Yuan, L., Moyon, D., Pardanaud, L., Bréant, C., Karkkainen, M. J., Alitalo, K., & Eichmann, A. (2002) · Development · doi:10.1242/dev.129.20.4797 · Cited by 632
A model for gene therapy of human hereditary lymphedema
Karkkainen, M. J., Saaristo, A., Jussila, L., Karila, K. A., Lawrence, E. C., Pajusola, K., Bueler, H., Eichmann, A., Kauppinen, R., Kettunen, M. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221449198 · Cited by 606
A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations
Matthews, W., Jordan, C. T., Wiegand, G. W., Pardoll, D., & Lemischka, I. R. (1991) · Cell · doi:10.1016/0092-8674(91)90010-v · Cited by 593
Olofsson, B., Korpelainen, E., Pepper, M. S., Mandriota, S. J., Aase, K., Kumar, V., Gunji, Y., Jeltsch, M. M., Shibuya, M., Alitalo, K., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11709 · Cited by 560
Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity
Swartz, M. A., & Lund, A. W. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3186 · Cited by 544
VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer
Valtola, R., Salven, P., Heikkilä, P., Taipale, J., Joensuu, H., Rehn, M., Pihlajaniemi, T., Weich, H., deWaal, R., & Alitalo, K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65392-8 · Cited by 541
Matthews, W., Jordan, C. T., Gavin, M., Jenkins, N. A., Copeland, N. G., & Lemischka, I. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9026 · Cited by 501
Kerjaschki, D., Regele, H. M., Moosberger, I., Nagy-Bojarski, K., Watschinger, B., Soleiman, A., Birner, P., Krieger, S., Hovorka, A., Silberhumer, G., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113316.52371.2e · Cited by 480
Soker, S., Miao, H., Nomi, M., Takashima, S., & Klagsbrun, M. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10140 · Cited by 456
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00521.x · Cited by 423
Vascular Endothelial Growth Factor Receptor-3 in Lymphangiogenesis in Wound Healing
Paavonen, K., Puolakkainen, P., Jussila, L., Jahkola, T., & Alitalo, K. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65021-3 · Cited by 398
Lymphatic vascular morphogenesis in development, physiology, and disease
Schulte-Merker, S., Sabine, A., & Petrova, T. V. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201012094 · Cited by 394
Harrell, M. I., Iritani, B. M., & Ruddell, A. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060761 · Cited by 388
Kudo, M., Han, G., Finn, R. S., Poon, R. T. P., Blanc, J.-F., Yan, L., Yang, J., Lu, L., Tak, W.-Y., Yu, X., et al. (2014) · Hepatology · doi:10.1002/hep.27290 · Cited by 355
Eggert, A., Ikegaki, N., Kwiatkowski, J. L., Zhao, H., Brodeur, G. M., & Himelstein, B. P. (2000) · PubMed · Cited by 353
Partanen, T. A., Arola, J., Saaristo, A., Jussila, L., Ora, A., Miettinen, M., Stacker, S. A., Achen, M. G., & Alitalo, K. (2000) · The FASEB Journal · doi:10.1096/fj.99-1049com · Cited by 346
Lund, A. W., Duraes, F. V., Hirosue, S., Raghavan, V. R., Nembrini, C., Thomas, S. N., Issa, A., Hugues, S., & Swartz, M. A. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.01.005 · Cited by 341
Neuropilin-2 mediates VEGF-C–induced lymphatic sprouting together with VEGFR3
Xu, Y., Yuan, L., Mak, J., Pardanaud, L., Caunt, M., Kasman, I., Larrivée, B., del Toro, R., Suchting, S., Medvinsky, A., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200903137 · Cited by 339
Pajusola, K., Aprelikova, O. N., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R., & Alitalo, K. K. (1992) · PubMed · Cited by 336
Ohta, Y., Shridhar, V, Bright, R. K., Kalemkerian, G. P., Du, W., Carbone, M., Watanabe, Y., & Pass, H. I. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690650 · Cited by 335
Vascular Endothelial Growth Factors VEGF-B and VEGF-C Are Expressed in Human Tumors
Salven, P., Lymboussaki, A., Heikkilä, P., Jääskela-Saari, H., Enholm, B., Aase, K., von Euler, G., Eriksson, U., Alitalo, K., & Joensuu, H. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65550-2 · Cited by 328
Lymphangiogenic factors, mechanisms, and applications
Zheng, W., Aspelund, A., & Alitalo, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71603 · Cited by 322
Yonemura, Y., Endo, Y., Fujita, H., Fushida, S., Ninomiya, I., Bandou, E., Taniguchi, K., Miwa, K., Ohoyama, S., Sugiyama, K., et al. (1999) · PubMed · Cited by 311
Partanen, T. A., Alitalo, K., & Miettinen, M. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11<2406::aid-cncr31>3.0.co;2-e · Cited by 304
Functional interaction of VEGF‐C and VEGF‐D with neuropilin receptors
Karpanen, T., Heckman, C. A., Keskitalo, S., Jeltsch, M., Ollila, H., Neufeld, G., Tamagnone, L., & Alitalo, K. (2006) · The FASEB Journal · doi:10.1096/fj.05-5646com · Cited by 299
Whitaker, G. B., Limberg, B. J., & Rosenbaum, J. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102315200 · Cited by 294
Yoh, K., Seto, T., Satouchi, M., Nishio, M., Yamamoto, N., Murakami, H., Nogami, N., Matsumoto, S., Kohno, T., Tsuta, K., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30322-8 · Cited by 294
Sawano, A., Takahashi, T., Yamaguchi, S., Aonuma, M., & Shibuya, M. (1996) · PubMed · Cited by 290
Vascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic System
Baldwin, M. E., Halford, M. M., Roufail, S., Williams, R. A., Hibbs, M. L., Grail, D., Kubo, H., Stacker, S. A., & Achen, M. G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2441-2449.2005 · Cited by 289
Niki, T., Iba, S., Tokunou, M., Yamada, T., Matsuno, Y., & Hirohashi, S. (2000) · PubMed · Cited by 288
A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy
Hägerling, R., Pollmann, C., Andreas, M., Schmidt, C., Nurmi, H., Adams, R. H., Alitalo, K., Andresen, V., Schulte-Merker, S., & Kiefer, F. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.340 · Cited by 288
Lin, J., Lalani, A. S., Harding, T. C., Gonzalez, M., Wu, W.-W., Luan, B., Tu, G. H., Koprivnikar, K., VanRoey, M. J., He, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0408 · Cited by 269
Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins
Herzog, Y., Kalcheim, C., Kahane, N., Reshef, R., & Neufeld, G. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00518-4 · Cited by 264
The role of the VEGF-C/VEGFR-3 axis in cancer progression
Su, J.-L., Yen, C.-J., Chen, P.-S., Chuang, S.-E., Hong, C.-C., Kuo, I.-H., Chen, H.-Y., Hung, M.-C., & Kuo, M.-L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603487 · Cited by 252
D’Alessio, S., Correale, C., Tacconi, C., Gandelli, A., Pietrogrande, G., Vetrano, S., Genua, M., Arena, V., Spinelli, A., Peyrin-Biroulet, L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72189 · Cited by 245
Neural guidance molecules regulate vascular remodeling and vessel navigation
Eichmann, A., Makinen, T., & Alitalo, K. (2005) · Genes & Development · doi:10.1101/gad.1305405 · Cited by 245
Lee, S.-H., Lee, J.-K., Ahn, M.-J., Kim, D.-W., Sun, J.-M., Keam, B., Kim, T. M., Heo, D. S., Ahn, J. S., Choi, Y.-L., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw559 · Cited by 244
VEGF‐C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF‐7 tumors
Mattila, M. M., Ruohola, J. K., Karpanen, T., Jackson, D. G., Alitalo, K., & Härkönen, P. L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10283 · Cited by 243
Jeltsch, M., Jha, S. K., Tvorogov, D., Anisimov, A., Leppänen, V.-M., Holopainen, T., Kivelä, R., Ortega, S., Kärpanen, T., & Alitalo, K. (2014) · Circulation · doi:10.1161/circulationaha.113.002779 · Cited by 242
Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation
Huggenberger, R., Ullmann, S., Proulx, S. T., Pytowski, B., Alitalo, K., & Detmar, M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100559 · Cited by 239
Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology
Witte, M. H., Bernas, M. J., Martin, C. P., & Witte, C. L. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1163 · Cited by 238
Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
Akagi, K., Ikeda, Y., Miyazaki, M., Abe, T., Kinoshita, J., Maehara, Y., & Sugimachi, K. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1396 · Cited by 230
Pajusola, K., Aprelikova, O. N., Pelicci, G., Weich, H. A., Claesson, L., & Alitalo, K. K. (1994) · PubMed · Cited by 195
VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain
Le Bras, B., Barallobre, M.-J., Homman-Ludiye, J., Ny, A., Wyns, S., Tammela, T., Haiko, P., Karkkainen, M. J., Yuan, L., Muriel, M.-P., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1646 · Cited by 178
Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer
Kurebayashi, J., Otsuki, T., Kunisue, H., Mikami, Y., Tanaka, K., Yamamoto, S., & Sonoo, H. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00844.x · Cited by 174
Salameh, A., Galvagni, F., Bardelli, M., Bussolino, F., & Oliviero, S. (2005) · Blood · doi:10.1182/blood-2005-04-1388 · Cited by 173
Zhang, Y., Lu, Y., Ma, L., Cao, X., Xiao, J., Chen, J., Jiao, S., Gao, Y., Liu, C., Duan, Z., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.013 · Cited by 172
Murakami, M., Iwai, S., Hiratsuka, S., Yamauchi, M., Nakamura, K., Iwakura, Y., & Shibuya, M. (2006) · Blood · doi:10.1182/blood-2006-04-016030 · Cited by 166
Tumor lymphangiogenesis and new drug development
Dieterich, L. C., & Detmar, M. J. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.011 · Cited by 159
Van Trappen, P. O., Steele, D., Lowe, D. G., Baithun, S., Beasley, N., Thiele, W., Weich, H., Krishnan, J., Shepherd, J. H., Pepper, M. S., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1467 · Cited by 147
Lim, J. Y., Yang, K. Y., Taylor‐Harding, B., Wiedemeyer, W. R., & Buckanovich, R. J. (2014) · Neoplasia · doi:10.1016/j.neo.2014.04.003 · Cited by 136
Hamrah, P., Chen, L., Zhang, Q., & Dana, M. R. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63630-9 · Cited by 135
Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status
Bhargava, P., & Robinson, M. O. (2011) · Current Oncology Reports · doi:10.1007/s11912-011-0154-3 · Cited by 135
Pujol, B. F., Lucibello, F. C., Zuzarte, M., Lütjens, P., Müller, R., & HAVEMANN, K. (2001) · European Journal of Cell Biology · doi:10.1078/0171-9335-00136 · Cited by 134
Lymphatic Vessels as Targets of Tumor Therapy?
Karpanen, T., & Alitalo, K. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.f37 · Cited by 130
Niida, S., Kondo, T., Hiratsuka, S., Hayashi, S., Amizuka, N., Noda, T., Ikeda, K., & Shibuya, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503544102 · Cited by 125
Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation
Leppänen, V.-M., Tvorogov, D., Kisko, K., Prota, A. E., Jeltsch, M., Anisimov, A., Markovic-Mueller, S., Stuttfeld, E., Goldie, K. N., Ballmer-Hofer, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301415110 · Cited by 122
Heckman, C. A., Holopainen, T., Wirzenius, M., Keskitalo, S., Jeltsch, M., Ylä‐Herttuala, S., Wedge, S. R., Jürgensmeier, J. M., & Alitalo, K. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5809 · Cited by 117
FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter.
Aprelikova, O. N., Pajusola, K., Partanen, J. M., Armstrong, E., Alitalo, R., Bailey, S. K., McMahon, J., Wasmuth, J. J., Huebner, K., & Alitalo, K. K. (1992) · PubMed · Cited by 116
Steitz, J., Br�ck, J., Steinbrink, K., Enk, A., Knop, J. X. F. R., & Tüting, T. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<15::aid-ijc3>3.0.co;2-b · Cited by 106
Muramatsu, M., Yamamoto, S., Osawa, T., & Shibuya, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0202 · Cited by 103
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays
Mehnert, J. M., McCarthy, M. M., Jilaveanu, L. B., Flaherty, K. T., Aziz, S. A., Camp, R. L., Rimm, D. L., & Kluger, H. M. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.08.016 · Cited by 101
Ghalamkarpour, A., Morlot, S., Raas‐Rothschild, A., Utkus, A., Mulliken, J. B., Boon, L., & Vikkula, M. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00687.x · Cited by 94
Alam, A., Blanc, I., Gueguen‐Dorbes, G., Duclos, O., Bonnin, J., Barron, P., Laplace, M.-C., Morin, G., Gaujarengues, F., Dol, F., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0866-t · Cited by 93
Orlandini, M., Spreafico, A., Bardelli, M., Rocchigiani, M., Salameh, A., Nucciotti, S., Capperucci, C., Frediani, B., & Oliviero, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600413200 · Cited by 86
Expression and localization of VEGF‐C and VEGFR‐3 in glioblastomas and haemangioblastomas
Jenny, B., Harrison, J., Baetens, D., Tille, J., Burkhardt, K., Mottaz, H., Kiss, J., Dietrich, P., de Tribolet, N., Pizzolato, G., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1943 · Cited by 83
Saif, M. W., Knost, J. A., Chiorean, E. G., Kambhampati, S. R. P., Yu, D., Pytowski, B., Qin, A., Kauh, J. S. W., & O’Neil, B. H. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3134-3 · Cited by 81
NRP-2 in tumor lymphangiogenesis and lymphatic metastasis
Wang, J., Huang, Y., Zhang, J., Xing, B., Wei, X., Wang, H., Huang, H., Yang, J., & Tang, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.040 · Cited by 78
Kaushal, V., Mukunyadzi, P., Dennis, R. A., Siegel, E. R., Johnson, D. E., & Kohli, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.584.11.2 · Cited by 76
Hwang, S. D., Song, J. H., Kim, Y., Lim, J. H., Kim, M. Y., Kim, E. N., Hong, Y. A., Chung, S., Choi, B. S., Kim, Y., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1436-1 · Cited by 75
Steroid-Resistant Lymphatic Remodeling in Chronically Inflamed Mouse Airways
Yao, L., Bałuk, P., Feng, J., & McDonald, D. M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090909 · Cited by 72
Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats
Chuffa, L. G. D. A., Zonta, Y. R., Martinez, M., Camargo, I. C. C., Domeniconi, R. F., Junior, L. A. L., Pinheiro, P. F. F., Reiter, R. J., & Martinez, F. E. [. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040763 · Cited by 72
Decio, A., Taraboletti, G., Patton, V., Alzani, R., Perego, P., Fruscio, R., Jürgensmeier, J. M., Giavazzi, R., & Belotti, D. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.12.030 · Cited by 70
Fournier, E., Dubreuil, P. C., Birnbaum, D., & Borg, J. (1995) · PubMed · Cited by 69
Jimenez, X., Lu, D., Brennan, L., Persaud, K., Liu, M., Miao, H., Witte, L., & Zhu, Z. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0261 · Cited by 64
Wang, J. E. H., Taylor, A., Showeil, R., Trivedi, P. S., Horimoto, Y., Bagwan, I., Ewington, L. J., Lam, E. W. ‐., & El-Bahrawy, M. A. (2014) · Cytokine · doi:10.1016/j.cyto.2014.04.005 · Cited by 58
Zhang, D., Li, B., Shi, J., Zhao, L., Zhang, X., Wang, C., Hou, S., Qian, W., Kou, G., Wang, H., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3488 · Cited by 58
Takizawa, H., Kondo, K., Fujino, H., Kenzaki, K., Miyoshi, T., Sakiyama, S., & Tangoku, A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603209 · Cited by 57
VEGF-C-VEGFR3/Flt4 axis regulates mammary tumor growth and metastasis in an autocrine manner.
Varney, M. L., & Singh, R. K. (2015) · Europe PMC (PubMed Central) · Cited by 50
Yeh, Y.-W., Cheng, C.-C., Yang, S.-T., Tseng, C.-F., Chang, T.-Y., Tsai, S.-Y., Fu, E., Chiang, C., Liao, L.-C., Tsai, P.-W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13629 · Cited by 50
Rinderknecht, M., Villa, A., Ballmer-Hofer, K., Neri, D., & Detmar, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011941 · Cited by 49
Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain
Roukens, M. G., Peterson-Maduro, J., Padberg, Y., Jeltsch, M., Leppänen, V.-M., Bos, F. L., Alitalo, K., Schulte-Merker, S., & Schulte, D. (2015) · Circulation Research · doi:10.1161/circresaha.116.304949 · Cited by 49
Koch, M., Dettori, D., Nuffelen, A. V., Souffreau, J., Marconcini, L., Wallays, G., Moons, L., Bruyére, F., Oliviero, S., Noël, A., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2605 · Cited by 48
GOUSSIA, A. C., Simou, N., Zagouri, F., Manousou, K., Lazaridis, G. T., Gogas, H. J., Koutras, A. K., Sotiropoulou, M. G., Pentheroudakis, G. E., Bafaloukos, D. I., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200302 · Cited by 46
Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer
Schimanski (1994) · Oncology Reports · doi:10.3892/or_00000081 · Cited by 42
Kubota, K., Yoshioka, H., Oshita, F., Hida, T., Yoh, K., Hayashi, H., Kato, T., Kaneda, H., Yamada, K., Tanaka, H., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.7297 · Cited by 42
Jeltsch, M., Kärpänen, T., Strandin, T. M., Aho, K., Lankinen, H., & Alitalo, K. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511593200 · Cited by 40
Zhu, G., Huang, Q., Zheng, W., Huang, Y., Jin, H., Yang, S., Zhuang, J., Wang, J., Chang, J., Xu, J., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447868 · Cited by 39
Al-Shareef, H., Hiraoka, S.-I., Tanaka, N., Shogen, Y., Lee, A., Bakhshishayan, S., & Kogo, M. (2016) · Oncology Reports · doi:10.3892/or.2016.5116 · Cited by 39
Apoptosis of human macrophages by Flt-4 signaling: Implications for atherosclerotic plaque pathology
Schmeißer, A., Christoph, M., Augstein, A., Marquetant, R., Kasper, M. E., Braun-Dullaeus, R. C., & Strasser, R. H. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.06.012 · Cited by 37
Pasquali, S., van der Ploeg, A. P. T., D, S. M. M., Stretch, J. R., Thompson, J. F., & Scolyer, R. A. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12064 · Cited by 37
Crucial role of corneal lymphangiogenesis for allograft rejection in alkali‐burned cornea bed
Ling, S., Qi, C., Li, W. S., Xu, J., & Kuang, W. (2009) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2009.02178.x · Cited by 34
Expression and Significances of Contactin-1 in Human Gastric Cancer
Yu, J., Wu, S., Lu, R., Wu, J., Ni, X., Zhou, G.-C., Jiang, H.-G., Zheng, L., Li, X., Du, G., et al. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/210205 · Cited by 32
Eroğlu, A., Ersöz, C. C., Karasoy, D., & Sak, S. D. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/58784 · Cited by 32
The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth
Kurenova, E., Liao, J., He, D.-H., Hunt, D. L., Yemma, M., Bshara, W., Seshadri, M., & Cance, W. G. (2013) · Oncotarget · doi:10.18632/oncotarget.1365 · Cited by 30
Yoshimoto, K., Ma, X., Guan, Y., Mizoguchi, M., Nakamizo, A., Amano, T., Hata, N., Kuga, D., & Sasaki, T. (2011) · Brain Tumor Pathology · doi:10.1007/s10014-011-0046-0 · Cited by 30
Paiva, T. F., de Jesus, V. H. F., Marques, R. A., da Costa, A. A. B. A., de Macêdo, M. P., Peresi, P. M., Damascena, A. S., Rossi, B. M., Begnami, M. D., & de Lima, V. C. C. (2015) · BMC Cancer · doi:10.1186/s12885-015-1648-4 · Cited by 28
Stark, D., Cook, A. D., Brown, J. M., Brundage, M., Embleton-Thirsk, A., Kaplan, R. S., Raja, F. A., Swart, A. M., Velikova, G., Qian, W., et al. (2017) · Cancer · doi:10.1002/cncr.30657 · Cited by 28
Lee, J. Y., Park, S., Kim, D. C., Yoon, J., Shin, S., Min, W.-S., & Kim, H. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9877-2 · Cited by 26
Bierer (1994) · Oncology Reports · doi:10.3892/or_00000065 · Cited by 25
Inhibition of FAK and VEGFR‐3 binding decreases tumorigenicity in neuroblastoma
Stewart, J. E., Ma, X., Megison, M. L., Nabers, H. C., Cance, W. G., Kurenova, E., & Beierle, E. A. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22070 · Cited by 23
Zhang, H., Fan, Q., Cao, Y., Zu, X., Chen, M., Li, Z., & Qi, L. (2013) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1303 · Cited by 23
Expression of VEGF receptors in cocultured neuroblastoma cells
Beierle, E. A., Dai, W., Langham, M. R., Copeland, E. M., & Chen, M. K. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.01.002 · Cited by 22
Mančíková, V., Inglada‐Pérez, L., Currás-Freixes, M., de Cubas, A. A., Gómez, Á., Letón, R., Kersten, I., Leandro-Garcia, L. J., Comino‐Méndez, I., Apellániz-Ruiz, M., et al. (2014) · Thyroid · doi:10.1089/thy.2013.0579 · Cited by 21
Wang, Z., Yao, C., Li, X., Xu, L., Ma, W., Chang, L., & Ju, F. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.1.027 · Cited by 21
Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas
Park, H., Min, K., Kim, H.-S., Jung, W. W., & Park, Y.-K. (2008) · Pathology - Research and Practice · doi:10.1016/j.prp.2008.01.015 · Cited by 21
Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma
Rodríguez‐Antona, C., Muñoz‐Repeto, I., Inglada‐Pérez, L., de Cubas, A. A., Mančíková, V., Cañamero, M., Maliszewska, A., Gómez, Á., Letón, R., Leandro-Garcia, L. J., et al. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0316 · Cited by 21
Dai, X., Liu, D., Liu, M.-X., Zhang, X., Wang, W., JIN, F., Qian, Y., Wang, X., Zhao, J., Wu, Y., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11407 · Cited by 21
VEGFR3 and CD31 as prognostic factors in renal cell cancer.
Virman, J. P., Bono, P., Luukkaala, T. H., Sunela, K. L., Kujala, P. M., & Kellokumpu‐Lehtinen, P. (2015) · PubMed · Cited by 20
Axitinib in metastatic renal cell carcinoma
Albiges, L. K., Gizzi, M., Carton, E., & Escudier, B. J. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1033408 · Cited by 19
Immunologic Tolerance: Role of the Regional Lymph Node
Friedlaender, M. H., & Baer, H. (1972) · Science · doi:10.1126/science.176.4032.312 · Cited by 18
Increased vessel density in psoriasis: involvement of lymphatic vessels in the papillary dermis
Fiedler, E., Helmbold, P., & Marsch, W. C. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08608.x · Cited by 18
Kurenova, E., Uçar, D. A., Liao, J., Yemma, M., Gogate, P. N., Bshara, W., Sunar, U., Seshadri, M., Hochwald, S. N., & Cance, W. G. (2014) · Cell Cycle · doi:10.4161/15384101.2015.941760 · Cited by 17
Batsi, O., Giannopoulou, I., Nesseris, I., Valavanis, C., Gakiopoulou, H., Patsouris, E., Arapandoni-Dadioti, P., & Lazaris, A. C. (2014) · PubMed · Cited by 17
Li, Y., Weng, Y., Zhong, L., Chong, H., Chen, S., Sun, Y., Li, W., & Shi, Q. (2017) · Oncology Reports · doi:10.3892/or.2017.5969 · Cited by 17
Associations of nm23H1, VEGF-C, and VEGF-3 Receptor in Human Prostate Cancer
Yang, Z., Xu, Y.-F., Huang, F., & Ding, G. (2014) · Molecules · doi:10.3390/molecules19056851 · Cited by 16
Friedlaender, M. H., Chisari, F. V., & Baer, H. (1973) · The Journal of Immunology · doi:10.4049/jimmunol.111.1.164 · Cited by 15
Targeting the C-terminal focal adhesion kinase scaffold in pancreatic cancer
Gogate, P. N., Kurenova, E., Ethirajan, M., Liao, J., Yemma, M., Sen, A., Pandey, R. K., & Cance, W. G. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.032 · Cited by 15
Shi, X., Chen, G., Xing, H., Weng, D., Bai, X., & Ma, D. (2007) · Oncology Reports · doi:10.3892/or.18.1.241 · Cited by 14
Hong, K. D., Lee, Y., Kim, B., Lee, S. I., & Moon, H. Y. (2013) · The American Surgeon · doi:10.1177/000313481307900232 · Cited by 12
Misawa, Y., Misawa, K., Kawasaki, H., Imai, A., Mochizuki, D., Ishikawa, R., Endo, S., Mima, M., Kanazawa, T., Iwashita, T., et al. (2017) · Tumor Biology · doi:10.1177/1010428317711657 · Cited by 10
The suppressive role of calcium sensing receptor in endometrial cancer
Xin, X., Zeng, X., Feng, D., Teng, H., Liu, S., Chi, S., Hu, Q., & Wang, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-19286-1 · Cited by 8
Immunohistochemical analysis on potential new molecular targets for esophageal cancer
Maurer, J., Schöpp, M., Thurau, K., Haier, J., Köhler, G., & Hummel, R. (2013) · Diseases of the Esophagus · doi:10.1111/dote.12065 · Cited by 7
Zhang, Y. H., Diao, L., Yang, Q., Duo, J., Liu, Y. X., Liu, S. X., & Yao, X. (2010) · PubMed · Cited by 6
Research works printed but not linked: 1
- Shushanov, 2000, Vegfc and vegfr3 expression in human thyroid pathologies, Int. J. Cancer, 86, 47, 10.1002/(sici)1097-0215(20000401)86:1<47::aid-ijc7>3.0.co;2-r · doi:10.1002/(sici)1097-0215(20000401)86:1<47::aid-ijc7>3.0.co;2-r
Cited by
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Tomuleasa, C., Tigu, A.-B., Munteanu, R., Moldovan, C.-S., Kegyes, D., Onaciu, A., Gulei, D., Ghiaur, G., Einsele, H., & Croce, C. M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01899-w · Cited by 260
VEGF signaling: Role in angiogenesis and beyond
Shaw, P., Dwivedi, S. K. D., Bhattacharya, R., Mukherjee, P., & Rao, G. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189079 · Cited by 215
Kaposiform hemangioendothelioma: current knowledge and future perspectives
Ji, Y., Chen, S., Yang, K., Xia, C., & Li, L. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-1320-1 · Cited by 187
Nagl, L., Horvath, L., Pircher, A., & Wolf, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00766 · Cited by 180
Endothelial cells in tumor microenvironment: insights and perspectives
Leone, P., Malerba, E., Susca, N., Favoino, E., Perosa, F., Brunori, G., Prete, M., & Racanelli, V. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1367875 · Cited by 167
Metadata
- Authors
- Hsu, M.-C., Pan, M.-R., & Hung, W.-C.
- Affiliations
- National Health Research Institutes (TW)
- Kaohsiung Medical University (TW)
- Corresponding author
- Hung, Wen-Chun
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-03-21
- Volume
- 8
- Issue
- 3
- Pages
- 270
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6468620
- OpenAlex
- W2925306628
- Cited by
- 67
- References
- 170
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 10 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 7 · 2019: 6
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Science and Technology, Taiwan (MOST 103-2320-B-400-014; 104-2320-B-400 -010-MY3 and 107-2320-B-400-012)
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Keywords
- VEGFR-3, VEGF-C, tumor growth, lymphangiogenesis, lymph node metastasis, lymphatic endothelial cells, tumor immune tolerance, anti-VEGF therapy, tumor progression
- MeSH terms
- Animals, Humans, Neoplasms, Signal Transduction, Vascular Endothelial Growth Factor Receptor-3, Lymphangiogenesis, Endothelial Cells, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.